Literature DB >> 6188042

Increased clastogenicity and decreased inhibition of DNA synthesis by neocarzinostatin and tallysomycin in ataxia telangiectasia lymphoid cells.

M M Cohen, S J Simpson.   

Abstract

Cytogenetic damage in cells cultured from normal individuals and patients with ataxia telangiectasia (A-T) and xeroderma pigmentosum (XP) was induced by the chemotherapeutic antibiotics neocarzinostatin (NCS), tallysomycin (TLM) and bleomycin (BLM). Chromosomal breakage was specifically elevated in A-T cells when compared to the other genotypes tested. Similar results were not observed with the clastogens mitomycin C (MMC) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) as all cells responded similarly. All 5 chemical agents caused a marked suppression of de novo DNA synthesis in normal and XP long-term lymphoid cell lines while the A-T cells seemed resistant to this effect of NCS, TLM and BLM.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188042     DOI: 10.1016/0167-8817(83)90016-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  Coupling of histone mRNA levels to radioresistant DNA synthesis in ataxia-telangiectasia cells.

Authors:  M F Lavin; J Houldsworth; S Kumar; J L Stein; G S Stein
Journal:  Mol Cell Biochem       Date:  1987-01       Impact factor: 3.396

2.  Study of chromatin structure in ataxia-telangiectasia cells.

Authors:  J Houldsworth; S Kumar; M F Lavin
Journal:  Mol Biol Rep       Date:  1986       Impact factor: 2.316

Review 3.  Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.

Authors:  Mark Ambrose; Richard A Gatti
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

Review 4.  Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect.

Authors:  P J McKinnon
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.